Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Rain Oncology Inc. (RAIN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2023 |
4
| Vellanki Avanish (Chairman and CEO) has filed a Form 4 on Rain Oncology Inc.|
Txns:
| Granted 266,500 options to buy
@ $1.21, valued at
$322.5k
Granted 133,250 options to buy
@ $1.21, valued at
$161.2k
|
|
| 08/11/2023 |
4
| Doebele Robert (See Remarks) has filed a Form 4 on Rain Oncology Inc.|
Txns:
| Granted 99,400 options to buy
@ $1.21, valued at
$120.3k
Granted 49,700 options to buy
@ $1.21, valued at
$60.1k
|
|
| 08/11/2023 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on Rain Oncology Inc.|
Txns:
| Granted 35,000 options to buy
@ $1.21, valued at
$42.4k
|
|
| 08/11/2023 |
4
| Radovich Peter (Director) has filed a Form 4 on Rain Oncology Inc.|
Txns:
| Granted 35,000 options to buy
@ $1.21, valued at
$42.4k
|
|
| 08/11/2023 |
4
| Nguyen Tran (Director) has filed a Form 4 on Rain Oncology Inc.|
Txns:
| Granted 35,000 options to buy
@ $1.21, valued at
$42.4k
|
|
| 08/11/2023 |
4
| Wolff Stefani (Director) has filed a Form 4 on Rain Oncology Inc.|
Txns:
| Granted 35,000 options to buy
@ $1.21, valued at
$42.4k
|
|
| 08/11/2023 |
4
| Hrustanovic Gorjan (Director) has filed a Form 4 on Rain Oncology Inc.|
Txns:
| Granted 35,000 options to buy
@ $1.21, valued at
$42.4k
|
|
| 08/11/2023 |
4
| Davis Aaron I. (Director) has filed a Form 4 on Rain Oncology Inc.|
Txns:
| Granted 35,000 options to buy
@ $1.21, valued at
$42.4k
|
|
| 08/11/2023 |
4
| Atkisson Erik (General Counsel and CCO) has filed a Form 4 on Rain Oncology Inc.|
Txns:
| Granted 60,251 options to buy
@ $1.21, valued at
$72.9k
|
|
| 08/11/2023 |
4
| Bruce Josephine (Principal Fin. & Acc. Officer) has filed a Form 4 on Rain Oncology Inc.|
Txns:
| Granted 10,800 options to buy
@ $1.21, valued at
$13.1k
|
|
| 06/01/2023 |
4
| TANG KEVIN C (10% Owner) has filed a Form 4 on Rain Oncology Inc.|
Txns:
| Bought 347,932 shares
@ $1.05, valued at
$365.3k
Bought 200,000 shares
@ $1, valued at
$200k
Bought 32,890 shares
@ $1.06, valued at
$34.9k
Bought 2,016 shares
@ $1.08, valued at
$2.2k
Bought 5,930 shares
@ $1.06, valued at
$6.3k
Bought 161,180 shares
@ $1.08, valued at
$174.1k
Bought 5,000 shares
@ $1.1, valued at
$5.5k
Bought 92,984 shares
@ $1.09, valued at
$101.4k
Bought 240,341 shares
@ $1.12, valued at
$269.2k
|
|
| 05/24/2023 |
4
| Boxer Capital, LLC (Director) has filed a Form 4 on Rain Oncology Inc.|
Txns:
| Sold 995,000 shares
@ $1.25, valued at
$1.2M
|
|
| 11/23/2022 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on Rain Therapeutics Inc.|
Txns:
| Bought 45,000 shares
@ $7.8, valued at
$351k
Bought 77,000 shares
@ $8.27, valued at
$636.8k
|
|
| 11/08/2022 |
4
| Davis Aaron I. (Director) has filed a Form 4 on Rain Therapeutics Inc.|
Txns:
| Bought 972,212 shares
@ $5.83, valued at
$5.7M
Bought 400,000 options to buy
@ $5.83, valued at
$2.3M
|
|
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| Vellanki Avanish (Chairman and CEO) has filed a Form 4 on Rain Therapeutics Inc.|
Txns:
| Bought 25,000 shares
@ $2.29, valued at
$57.3k
|
|
| 04/15/2022 |
4
| Vellanki Avanish (Chairman and CEO) has filed a Form 4 on Rain Therapeutics Inc.|
Txns:
| Gifted 59,618 shares
@ $0
Gifted 59,618 shares
@ $0 |
|
| 04/15/2022 |
4
| Doebele Robert (See Remarks) has filed a Form 4 on Rain Therapeutics Inc.|
Txns:
| Exercised 3,000 options to buy
@ $3.95, valued at
$11.9k
|
|
| 04/04/2022 |
4
| Doebele Robert (See Remarks) has filed a Form 4 on Rain Therapeutics Inc.|
Txns:
| Exercised 2,000 options to buy
@ $3.95, valued at
$7.9k
|
|
| 03/15/2022 |
4
| Vellanki Avanish (President and CEO) has filed a Form 4 on Rain Therapeutics Inc.|
Txns:
| Exercised 14,468 options to buy
@ $4, valued at
$57.9k
|
|
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2022 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on Rain Therapeutics Inc.|
Txns:
| Bought 255,500 shares
@ $12, valued at
$3.1M
Bought 61,343 shares
@ $11.9984, valued at
$736k
Bought 226,079 shares
@ $12, valued at
$2.7M
Bought 14,806 shares
@ $12, valued at
$177.7k
|
|
| 10/13/2021 |
4
| PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on Rain Therapeutics Inc.|
Txns:
| Sold 13,082 shares
@ $14.8, valued at
$193.6k
Sold 286 shares
@ $15.05, valued at
$4.3k
Sold 5,038 shares
@ $12.9, valued at
$65k
Sold 2,462 shares
@ $13.66, valued at
$33.6k
Sold 12,475 shares
@ $12.03, valued at
$150.1k
Sold 9,351 shares
@ $13.15, valued at
$123k
Sold 7,306 shares
@ $13.4, valued at
$97.9k
|
|
| 09/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|